Treatment of Cutaneous Amoebiasis in Fulminant Amebic Colitis with Bowel Perforation or Peritonitis
Clinical Scenario
This protocol addresses cutaneous amoebiasis occurring in the context of fulminant amebic colitis complicated by one or more of the following critical conditions:
Bowel perforation
Peritonitis
Bowel necrosis
Toxic megacolon
Patients with fulminant amebic colitis will additionally require fluid resuscitation, broad-spectrum antimicrobial therapy for peritonitis, intensive supportive care, and surgical intervention for bowel perforation and bowel necrosis. Occasionally, colectomy has been necessitated by the development of toxic megacolon or extensive bowel necrosis.
Treatment Approach
Management combines antiparasitic therapy — delivered intravenously given the severity of presentation — with aggressive systemic support. This includes fluid resuscitation, broad-spectrum antimicrobial coverage for peritonitis, and intensive supportive care. Surgical intervention is a required component when bowel perforation, necrosis, or toxic megacolon is present.
The complete regimen — including agent selection, sequencing, and the required luminal follow-on therapy — is detailed in the full structured protocol.
References
DOI: 10.1093/ofid/ofy161
- Patients with fulminant amebic colitis will additionally require fluid resuscitation, broad-spectrum antimicrobial therapy for peritonitis, intensive supportive care, and surgical intervention for bowel perforation and bowel necrosis.
- Occasionally, colectomy has been necessitated by the development of toxic megacolon or extensive bowel necrosis.
- In patients who are unable to tolerate or absorb oral metronidazole, intravenous metronidazole should be used.
- The nitroimidazoles do not effectively eradicate luminal cysts and must be followed by a luminal agent.
View source ↗